Barclays analyst, Jeremy Campbell, reiterated his Overweight rating on shares of CME Group (NASDAQ: CME) and cut his price target ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE